Zoletil 100 Vet. 50 + 50 mg/ml pulver og solvens til injektionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

zoletil 100 vet. 50 + 50 mg/ml pulver og solvens til injektionsvæske, opløsning

virbac s.a. - tiletaminhydrochlorid, zolazepamhydrochlorid - pulver og solvens til injektionsvæske, opløsning - 50 + 50 mg/ml

Zoletil 50 Vet. 25 + 25 mg/ml pulver og solvens til injektionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

zoletil 50 vet. 25 + 25 mg/ml pulver og solvens til injektionsvæske, opløsning

virbac s.a. - tiletaminhydrochlorid, zolazepamhydrochlorid - pulver og solvens til injektionsvæske, opløsning - 25 + 25 mg/ml

Zoletil 100 Vet. 50 + 50 mg/ml pulver og solvens til injektionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

zoletil 100 vet. 50 + 50 mg/ml pulver og solvens til injektionsvæske, opløsning

pharmaménta aps - tiletaminhydrochlorid, zolazepamhydrochlorid - pulver og solvens til injektionsvæske, opløsning - 50 + 50 mg/ml

Spravato Den Europæiske Union - dansk - EMA (European Medicines Agency)

spravato

janssen-cilag international nv - esketamine hydrochlorid - depressiv lidelse - andre antidepressiva - spravato, i kombination med en ssri eller snri, er angivet for voksne med behandling-resistent depressiv lidelse, der ikke har reageret på mindst to forskellige behandlinger med antidepressiva i den nuværende moderat til svær depressiv episode.

Esketamine "Orifarm" 5 mg/ml injektions-/infusionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

esketamine "orifarm" 5 mg/ml injektions-/infusionsvæske, opløsning

orifarm generics a/s - esketaminhydrochlorid - injektions-/infusionsvæske, opløsning - 5 mg/ml

Zolsketil pegylated liposomal Den Europæiske Union - dansk - EMA (European Medicines Agency)

zolsketil pegylated liposomal

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

Desloratadine ratiopharm Den Europæiske Union - dansk - EMA (European Medicines Agency)

desloratadine ratiopharm

ratiopharm gmbh - desloratadin - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistaminer til systemisk brug, - desloratadine ratiopharm is indicated in adults for the relief of symptoms associated with:allergic rhinitischronic idiopathic urticaria as initially diagnosed by a physician.

Azomyr Den Europæiske Union - dansk - EMA (European Medicines Agency)

azomyr

n.v. organon - desloratadin - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistaminer til systemisk brug, - azomyr is indicated for the relief of symptoms associated with:allergic rhinitis (see section 5. 1)urticaria (see section 5.

Esketamine "Orifarm" 25 mg/ml injektions-/infusionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

esketamine "orifarm" 25 mg/ml injektions-/infusionsvæske, opløsning

orifarm generics a/s - esketaminhydrochlorid - injektions-/infusionsvæske, opløsning - 25 mg/ml